(34) have found that mutant WT1 is associated with DNA hypermethylation of polycomb repressor complex 2 targets in AML, and inhibitor of enhancer of zeste homolog 2 (EZH2) may be helpful in this AML subtype. The gene discussed is WT1; the disease is acute myeloid leukemia.